Frank Toner graduated with an honors degree in pharmacology from the University of Edinburgh. He joined Inveresk Research (acquired by Charles River in 2004) specializing in in vitro skin penetration. After serving as a study director, he became manager of dermal services and currently oversees the operations of 25 dedicated staff in this field.
Frank has presented at many meetings and has authored and co-authored many posters and abstracts as well as peer-reviewed papers. His publications feature work on the development and validation of compromised skin models in vitro, assessment of bioequivalence in vitro, the use of skin absorption data to refine the quantitative skin sensitization risk assessments, and the assessment of absorption and metabolism through human skin in vitro. He is an ILM-qualified business coach.
- An in vitro Skin Penetration Model for Compromised Skin: Estimating Penetration of Polyethylene Glycol [14C]-PEG-7 Phosphate. Skin Pharmacology and Physiology 2015;28:12–21. (2015)
- Use of an in vitro human skin permeation assay to assess bioequivalence of two topical cream formulations containing butenafine hydrochloride (1%, w/w). Regulatory Toxicology and Pharmacology 82; 14-19. (2016)
- Application of In Vitro Skin Penetration Measurements to Confirm and Refine the Quantitative Skin Sensitization Risk Assessment of Methylisothiazolinone. Regulatory Toxicology and Pharmacology 91, 197-207. (2017)
- In Vitro Percutaneous Absorption and Metabolism of Bosphenol A (BPA) Through Fresh Human Skin. Toxicology In Vitro 47, 147-155. (2016)